A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry
Recruiting
Observational Study
Rectal Cancer
Rectosigmoid Cancer
Rectosigmoid Junction Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Samsung Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age : 18 \~ 80 year old male or female
* Biopsy-proven adenocarcinoma
* Rectal cancer or Rectosigmoid junction cancer
* Primary cancer
* Non-metastatic cancer
* Planned (or elective) curative resection
* Low anterior resection with double-stapled technique
Exclusion Criteria:…
Contacts